2020 FDA/EMA approvals for new immunotherapy drug technologies and applications
Immunotherapy is a new approach applied in treatment of infections, autoimmune diseases, or cancer by activating or suppressing the immune system. Pre-clinical and clinical investigations on discovering new products with high efficacy and low side effects are still ongoing. Clinical studies revealed...
Main Authors: | Maryam Monajati, Samira Sadat Abolmaali, Alimohammad Tamaddon |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2021-06-01
|
Series: | Trends in Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://tips.sums.ac.ir/article_47547_358feb48438ffba2e2a2e611fe8151ab.pdf |
Similar Items
-
The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules
by: Beatriz G. de la Torre, et al.
Published: (2021-01-01) -
The Evolution of Cancer Immunotherapy
by: Meshaal Khan, et al.
Published: (2021-06-01) -
Antibody–Drug Conjugates for Cancer Therapy
by: Adam C. Parslow, et al.
Published: (2016-07-01) -
Improving Immunotherapy Through Glycodesign
by: Matthew J. Buettner, et al.
Published: (2018-11-01) -
Strategies of current cancer immunotherapy
by: Zuzanna Rzepka, et al.
Published: (2019-12-01)